1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Epiomic Epidemiology Series: Onychomycosis Forecast in 10 Major Markets 2015-2025

Summary

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Onychomycosis in 10 Major Markets
Onychomycosis is a fungal infection of the nail which occurs in the hands or feet. The more notable causative agents include the fungal pathogens Trichophyton rubrum and Trichophyton mentagrophytes. This report provides the current prevalent population for Onychomycosis across 10 Major Markets (USA, France, Germany, Italy, Spain, UK, Poland, Brazil, Japan and India) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors and prevention, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team at Black Swan, several of the main symptoms and co-morbidities of Onychomycosis have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

Main symptoms and co-morbidities for Onychomycosis include:

-Tinea pedis infections
-Diabetes
-Peripheral vascular disease
-HIV / AIDS
-Hypercholesterolaemia
-Osteoarticular disease
-Psoriasis

This report is built using data and information sourced from the proprietary Epiomic patient segmentation database. To generate accurate patient population estimates, the Epiomic database utilises a combination of several world class sources that deliver the most up to date information form patient registries, clinical trials and epidemiology studies. All of the sources used to generate the data and analysis have been identified in the report.

Reason to buy

-Able to quantify patient populations in global Onychomycosis’s market to target the development of future products, pricing strategies and launch plans.
-Gain further insight into the prevalence of the subdivided types of Onychomycosis and identify patient segments with high potential.
-Delivery of more accurate information for clinical trials in study sizing and realistic patient recruitment for various countries.
-Useful in the identification and trend of the prevalence numbers for the different causative agents of Onychomycosis.
-Provide a level of understanding on the impact from specific co-morbid conditions on Onychomycosis’s prevalent population.
-Identify sub-populations within Onychomycosis which require treatment.
-Gain an understanding of the specific markets that have the largest number of Onychomycosis patients.

Table Of Contents

Epiomic Epidemiology Series: Onychomycosis Forecast in 10 Major Markets 2015-2025
Onychomycosis
Table of Contents
-List of Tables and Figures
-Overview
-Introduction
-Cause of the Disease
-Risk Factors and Prevention
-Diagnosis of the Disease
-Variation by Geography/Ethnicity
-Disease Prognosis andClinical Course
-Key Co-morbid Conditions/Features Associated with the Disease
-Methodology for Quantification of Patient Numbers
-Top-Line Prevalence for Onychomycosis
-Main Causative Agent
-Average Duration of Disease
-Significant Co-morbidities of Disease
-Main Signs of Infection
-References
-Appendix


List of Tables and Figures
-Prevalence of clinically diagnosed onychomycosis, total (000s)
-Prevalence of clinically diagnosed onychomycosis, males (000s)
-Prevalence of clinically diagnosed onychomycosis, females (000s)
-Clinically diagnosed onychomycosis by type at presentation, total (000s)
-Clinically diagnosed onychomycosis by site of infection, total (000s)
-Clinically diagnosed onychomycosis by main type of fungal pathogen, total (000s)
-Clinically diagnosed onychomycosis by average duration of disease, total (000s)
-Clinically diagnosed onychomycosis patients with diabetes, total (000s)
-Clinically diagnosed onychomycosis patients with tinea pedis, total (000s)
-Clinically diagnosed onychomycosis patients with hyperkeratosis, total (000s)
-Clinically diagnosed onychomycosis patients with onycholysis, total (000s)
-Clinically diagnosed onychomycosis patients with paronychia, total (000s)
-USA Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-USA Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-France Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-France Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Germany Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Germany Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Italy Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Italy Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Spain Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Spain Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-United Kingdom Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-United Kingdom Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Poland Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Poland Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Brazil Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Brazil Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-Japan Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-Japan Prevalence of onychomycosis by 5-yr age cohort, females (000s)
-India Prevalence of onychomycosis by 5-yr age cohort, males (000s)
-India Prevalence of onychomycosis by 5-yr age cohort, females (000s)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

Global AntiFungal Agents Market Insights, Opportunity, Analysis, Market Shares And Forecast 2016 – 2022

  • $ 3900
  • Industry report
  • November 2016
  • by Occams

The global antifungal agents market was estimated to grow around $10,200 million and it is expected to experience robust growth during 2016-2022.Antifungal agent is basically a drug which helps in detecting ...

Global Antifungal Agents Market Report 2016

Global Antifungal Agents Market Report 2016

  • $ 2850
  • Industry report
  • August 2016
  • by 9Dimen Research

2016 Global Antifungal Agents Report is a professional and in-depth research report on the world's major regional market conditions of the Antifungal Agents industry, focusing on the main regions (North ...

Global Terbinafine Market Research Report 2016

Global Terbinafine Market Research Report 2016

  • $ 2850
  • Industry report
  • October 2016
  • by 9Dimen Research

2016 Global Terbinafine Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Terbinafine industry, focusing on the main regions (North America, ...


Download Unlimited Documents from Trusted Public Sources

OTC Industry in the US

  • November 2016
    52 pages
  • United States  

View report >

Global Livestock Industry

  • September 2016
    4 pages
  • Livestock  

    Antiseptics  

    Food  

  • World  

    Sweden  

View report >

Therapy Market in New Zealand

  • July 2016
    24 pages
  • Therapy  

    Anti-Infective  

    Antifungal  

  • New Zealand  

View report >

Otc Markets In The Us

8 months ago

Otc Industry In Canada

11 months ago

Related Market Segments :

Antifungal
Infectious Disease

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.